<DOC>
	<DOC>NCT01669980</DOC>
	<brief_summary>This is a study of safety and effectiveness of ceftaroline fosamil in children with Complicated Community-acquired Pneumonia receiving antibiotic therapy in the hospital.</brief_summary>
	<brief_title>Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)</brief_title>
	<detailed_description>To evaluate safety, effectiveness, pharmacokinetics and tolerance of ceftaroline fosamil in pediatric subjects ages 2 months to &lt; 18 years who are initially hospitalized with Complicated Community Acquired Bacterial Pneumonia (CABP) at high risk of infection due to methicillin-resistant Staphylococcus aureus (MRSA)</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Ceftriaxone</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Cephalosporins</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Presence of CABP warranting 3 days of initial hospitalization Confirmed presence of indicators of complicated CABP Hypersensitivity or allergic reaction to vancomycin or any Î²lactam antimicrobial Confirmed or suspected infection with a pathogen known to be resistant to IV study drugs or known infection at baseline with a sole atypical organism Confirmed or suspected respiratory tract infection attributable to sources other than community acquired bacterial pneumonia Noninfectious causes of pulmonary infiltrates</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Infections</keyword>
	<keyword>Pediatrics</keyword>
	<keyword>Teflaro</keyword>
	<keyword>Ceftriaxone</keyword>
	<keyword>cephalosporin</keyword>
	<keyword>Vancomycin</keyword>
	<keyword>Clindamycin</keyword>
	<keyword>Amoxicillin Clavulanate</keyword>
	<keyword>Linezolid</keyword>
	<keyword>MRSA</keyword>
	<keyword>pneumonia</keyword>
</DOC>